State of the Science Summit - Gynecologic Cancers: Chaired by Aditya Bardia, MD, MPH and Laura Spring, MD

Commentary
Article

State of the Science Summit - Gynecologic Cancers: Chaired by Aditya Bardia, MD, MPH and Laura Spring, MD

State of the Science Summit - Gynecologic Cancers: Chaired by Aditya Bardia, MD, MPH and Laura Spring, MD

Speakers

  • Seth Wander, MD, PhD | Mass General Cancer Center
  • Charlie Dai, MD | Dana-Farber Cancer Institute
  • Arielle Medford, MD | Mass General Cancer Center
  • Neelima Vidula, MD | Mass General Cancer Center
  • Jennifer Hutchinson, PharmD | Mass General Cancer Center

Topics

  • CDK 4/6 Inhibitors in HR+/HER2- Breast Cancer
  • Beyond CDK4/6 in Metastatic Breast Cancer
  • Case Presentation: HR+/HER2- Breast Cancer
  • Updates in HER2+ and HER2-low Breast Cancer
  • Novel Targets in Breast Cancer
  • ADCs: Management of Adverse Events

Interested in attending a live or virtual event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
Erin Frances Cobain, MD
Video 6 - "Shared Decision Making and Multidisciplinary Collaboration in the Evolving HR+/HER2- Early-Stage Breast Cancer Landscape"
Manmeet Singh Ahluwalia, MD
Rita Nanda, MD
Video 5 - "AE Management with CDK4/6 Inhibitors: Strategies for Treatment Continuity and Optimal Patient Outcomes"
Rita Nanda, MD
Siddartha Yadav, MD, FACP
Nan Chen, MD
Video 4 - "The Evolving Treatment Landscape with CDK4/6 Inhibitors in Early HR+/HER2- Breast Cancer"
Margaret E. Gatti-Mays, MD, MPH, FACP, of The Ohio State University Comprehensive Cancer Center